PubMed COVID-19 Clinical Care

No abstract

CONCLUSION: Present findings indicate the negative effects of the COVID-19 pandemic on a variety of academic and administrative aspects at U.S. pharmacy schools. These findings could provide useful information to stakeholders in pharmacy academia.

CONCLUSION: This data shows an increase of adaptive immunity in CVID after mRNA vaccination in parallel to boosters, accrual number of exposures and formation of hybrid immunity.

CONCLUSIONS: The COVID-19 pandemic, reducing the possibility of microbial spread following to the lockdown and, in addition, to the constant use of face masks and other personal protective equipment, the frequent hand-washing, more ventilation of the

While mRNA vaccine efficacy against the 2019 coronavirus disease (COVID-19) outbreak remains high, research on antiviral innate immune responses in the early stages of infection is essential to develop strategies to prevent the dissemination of SARS

CONCLUSION: In this cross-sectional study, aPL and particularly aβ2GPI-IgA were common in patients with COVID-19.

We examine the dynamics and spillover effects of interconnectedness among equity indices during the COVID-19 pandemic and the Russian-Ukrainian war. Using daily data from June 2010 to May 2023, we consider five major equity indices, namely, the Dow

Evidence in SARS-CoV-2 patients have identified that viral infection is accompanied by the expression of inflammatory mediators by both immune and stromal cells within the pulmonary system. However, the immunogenicity of individual SARS-CoV-2

CONCLUSION: We suggest that PNI could serve as a reliable prognostic index in covid-19 patients. Reduced level of PNI should alert physicians since it is associated with need for hospitalization and mortality in this population.

CONCLUSIONS: The findings of this meta-analysis demonstrate that ACVs may have a superior effect and an acceptable safety in preventing COVID-19. Although these results suggest the potential of ACVs, further studies are required.